CRPPA and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: ISPD mutations account for 9–11 % of the most severe dystroglycanopathy variants (comprising CMD, WWS, and cobblestone lyssencephaly) in three large cohorts from different ethnic backgrounds [13, 14, 17].